Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

BHVN Biohaven Ltd

0.80 (2.42%)
Last Updated: 10:13:55
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Biohaven Ltd BHVN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.80 2.42% 33.79 10:13:55
Open Price Low Price High Price Close Price Prev Close
33.22 33.01 34.24 32.99
more quote information »

Recent News

Date Time Source Heading
5/29/202407:30PRNUSBiohaven Showcases Broad Innovative Portfolio and Pipeline..
5/29/202407:15PRNUSBiohaven Doses First Patient with its Novel Trop-2 Directed..
5/17/202416:42EDGAR2Form 8-K - Current report
5/17/202416:41EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
5/09/202416:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
5/09/202416:14EDGAR2Form 8-K - Current report
5/09/202416:05PRNUSBiohaven Reports First Quarter 2024 Financial Results and..
4/22/202416:05PRNUSBiohaven Announces Closing of Public Offering and Full..
4/17/202416:05PRNUSBiohaven Announces Proposed Public Offering of Common Shares
4/13/202409:00PRNUSBiohaven Showcases Innovative Neuroscience Portfolio with 20..
2/29/202416:16EDGAR2Form 8-K - Current report
2/29/202416:05PRNUSBiohaven Reports Fourth Quarter and Full Year 2023 Financial..
1/08/202407:30EDGAR2Form 8-K - Current report
1/08/202407:30PRNUSBiohaven Highlights Progress Across Innovative Portfolio and..
1/02/202407:00PRNUSBiohaven to Present at the 42nd Annual J.P. Morgan..
12/01/202316:30PRNUSBiohaven Presents Expanded EEG and Safety Data for BHV-7000..
11/14/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/14/202316:05PRNUSBiohaven Reports Third Quarter 2023 Financial Results and..
10/16/202307:00PRNUSBiohaven Presents Preclinical Data Demonstrating..
10/05/202316:05EDGAR2Form 8-K - Current report
10/05/202316:05PRNUSBiohaven Announces Closing of Public Offering and Full..
10/04/202316:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/202323:56PRNUSBiohaven Announces Pricing of $225 Million Public Offering..
10/02/202321:41EDGAR2Form 8-K - Current report
10/02/202317:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/202317:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/202316:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
9/27/202306:58EDGAR2Form 8-K - Current report
9/14/202307:00PRNUSBiohaven Completes Enrollment in Pivotal Phase 3 Study of..
9/05/202307:00PRNUSBiohaven Announces Positive Data from its Exploratory..
7/31/202317:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/31/202316:29EDGAR2Form 8-K - Current report
7/31/202309:31PRNUSBiohaven's Taldefgrobep Alfa Receives EU Orphan Drug..
7/31/202306:59PRNUSBiohaven Reports Second Quarter 2023 Financial Results and..
7/28/202316:35EDGAR2Form 8-K - Current report
7/27/202308:42DJNBiohaven Told That FDA Won't Review NDA Application for..
7/27/202307:00PRNUSBiohaven Provides Preliminary EEG Data Update for Kv7..

Your Recent History

Delayed Upgrade Clock